PDCD1 and neoplasm: In another study, CAR-T cells armed with autocrine PD-L1 scFv antibody reversed exhaustion and enhanced anti-tumor immune response in solid tumors and hematologic malignancies by blocking the PD-1/PD-L1 signaling (228).